. . . . . . . . "A retrospective chart review evaluated outcomes for 5 young adult inpatients with treatment-resistant schizophrenia who were prescribed off-label oxytocin (OT; 10 IU/sublingual, 1 time per day, to 20 IU/sublingual, 3 times per day) after their therapeutic response to clozapine plateaued (dose range: 200 to 600 mg). The augmented treatment was well tolerated and continued for at least 1 year after discharge from the hospital, with continued outpatient follow-up by the treating psychiatrist. Evaluation included the Positive and Negative Syndrome Scale and clinical review based on both self and parent/guardian reports." . . . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "Wa0ALDSr4UufGWCqblxQi+ZJp6NNebgVfS3tWOgc2U+3hbJ5Vt9MLY9sDnUzFi/iCKxKRZcFIgEsxbuSxwyeJJBbgM5l72seHUA8YWXb8Jt1PEeWbUf6sGfV44Rzl5lX5CTKY3jMsmbqYlqtvX3/Q+wXEwWcG72Sh1RJvCBZ3+0=" . . "2021-05-24T17:43:15.737+02:00"^^ . . . . .